• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DNA GENOTEK ORE-100; ORAL SALIVA COLLECTION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DNA GENOTEK ORE-100; ORAL SALIVA COLLECTION DEVICE Back to Search Results
Catalog Number ORE-100
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Abdominal Pain (1685); Fatigue (1849); Headache (1880); Hypersensitivity/Allergic reaction (1907); Burning Sensation (2146); Numbness (2415); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 11/16/2021
Event Type  malfunction  
Event Description
On (b)(6) 2021, a female individual contacted dna genotek regarding irritation in her mouth after swabbing her mouth with the ore-100 device for purposes of collecting a saliva sample for use with clarifi covid-19 testing in a school setting.The complaint was forwarded to quadrant biosciences on (b)(6) 2022.After reaching out to the individual, she indicated on (b)(6) 2022 the symptoms consisted of a burning sensation, tingling, numbness on the left side of her face, fatigue, stomach ache and headaches.The suspect medical device, ore-100, is used to collect saliva for use with the clarifi covid-19 test kit (b)(4).Ore-100 is manufactured by dna genotek and is included in the clarifi covid-19 test kit manufactured by quadrant biosciences as the device for collecting saliva specimens for testing with the clarifi test kit.In (b)(6) 2021, an individual swabbed the inside of her mouth using ore-100 for purposes of collecting a saliva sample for use with clarifi covid-19 testing in a school setting and experienced irritation.The individual contacted the dna genotek support team.Following the initial contact, the dna genotek team made several attempts to gather information from the individual with no response.On (b)(6) 2022, the complaint was forwarded to quadrant biosciences.After two attempts to gather information, the individual responded on (b)(6) 2022 that the symptoms they experienced in (b)(6) 2021 consisted of burning sensation, tingling and numbness on the left side of her face.The individual indicated after the first three occasions of administering the swab prior to (b)(6) 2021, the burning sensation, headache, fatigue and stomach ache experienced lasted for approximately 12 hours.When the individual administered the swab on (b)(6) 2021, they indicated the symptoms consisted of a burning sensation, tingling, numbness on the left side of her face, fatigue, stomach ache and headaches that lasted for two days, prompting her to contact her doctor.The doctor prescribed an epi pen as the individual does have preexisting latex sensitivity and chronic allergies.This submission is being made out of an abundance of caution, because medical intervention occurred and the potential severity of the individual's apparent reaction to contact with the ore-100 is unknown to the lack of any documented vital signs by the doctor, which would be used to predict the severity of the apparent reaction to the ore-100 to prompt the prescription of a safeguard in the event of the need for future medical intervention.
 
Manufacturer Narrative
Complaint was received by manufacturer, dna genotek on (b)(6) 2021.The complaint was forwarded to quadrant biosciences inc on (b)(6) 2022.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORE-100
Type of Device
ORAL SALIVA COLLECTION DEVICE
Manufacturer (Section D)
DNA GENOTEK
3000-500 palladium drive
ottawa, ontario K2V 1 C2
CA  K2V 1C2
Manufacturer (Section G)
DNA GENOTEK
3000-500 palladium drve
ottawa, ontario K2V 1 C2
CA   K2V 1C2
Manufacturer Contact
bryan greene
505 irving ave
suite 3100ab
syracuse, NY 13210
3153824468
MDR Report Key13660025
MDR Text Key296762185
Report Number3013712511-2022-00003
Device Sequence Number1
Product Code OYJ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility,Distributor
Reporter Occupation Other
Remedial Action Notification
Type of Report Initial
Report Date 03/02/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/03/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date04/30/2023
Device Catalogue NumberORE-100
Device Lot NumberYD503
Was Device Available for Evaluation? No
Date Manufacturer Received11/16/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age49 YR
Patient SexFemale
-
-